Can a community app curb Opioid-Linked HIV and hepatitis in rural america?
NCT ID NCT05363865
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This study tested a digital, community-led program in rural Appalachia and the Midwest to help people get tested and treated for HIV and hepatitis C, and reduce risks from opioid use. About 511 adults from high-risk counties took part, with half currently using illicit substances and half not. The program aimed to increase testing, treatment, and harm reduction like using Narcan and syringe services.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19103, United States
Conditions
Explore the condition pages connected to this study.